Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Neuropharmacology. 2016 Dec 9;116:1–8. doi: 10.1016/j.neuropharm.2016.12.005

Figure 7.

Figure 7

Increase in self-administration at Weeks 5–6 following active vaccination at Weeks 0, 2 and 4. Mean (n=9–10) infusions of α-PVP (0.025 mg/kg/inf) obtained per 3 sessions under a fixed-ratio 1 (FR1) response contingency. Significant differences within group from all acquisition conditions are indicated by *.